PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
46.24
+0.99 (2.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
PTC Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Hold
Price Target
$51.85
Upside
+12.13%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $45 → $67 | Hold → Buy | Upgrades | $45 → $67 | +44.90% | Dec 13, 2024 |
| Citigroup | Citigroup | Strong Sell Maintains $26 → $32 | Strong Sell | Maintains | $26 → $32 | -30.80% | Dec 4, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $42 | Strong Sell | Maintains | $32 → $42 | -9.17% | Dec 4, 2024 |
| UBS | UBS | Strong Buy Maintains $47 → $71 | Strong Buy | Maintains | $47 → $71 | +53.55% | Dec 3, 2024 |
| Baird | Baird | Buy Maintains $52 → $70 | Buy | Maintains | $52 → $70 | +51.38% | Dec 3, 2024 |
| Barclays | Barclays | Hold Maintains $45 → $56 | Hold | Maintains | $45 → $56 | +21.11% | Dec 3, 2024 |
| Baird | Baird | Buy Maintains $48 → $52 | Buy | Maintains | $48 → $52 | +12.46% | Nov 27, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $56 → $68 | Buy | Maintains | $56 → $68 | +47.06% | Nov 26, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $51 → $62 | Buy | Maintains | $51 → $62 | +34.08% | Nov 19, 2024 |
| Barclays | Barclays | Hold Maintains $43 → $45 | Hold | Maintains | $43 → $45 | -2.68% | Nov 14, 2024 |
| Barclays | Barclays | Hold Maintains $31 → $43 | Hold | Maintains | $31 → $43 | -7.01% | Nov 11, 2024 |
| Baird | Baird | Buy Maintains $44 → $48 | Buy | Maintains | $44 → $48 | +3.81% | Nov 8, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $45 | Hold | Maintains | $32 → $45 | -2.68% | Oct 11, 2024 |
| Baird | Baird | Buy Reiterates $44 | Buy | Reiterates | $44 | -4.84% | Oct 8, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $32 → $34 | Hold | Maintains | $32 → $34 | -26.47% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $64 | Buy | Reiterates | $64 | +38.41% | Sep 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.